- Home
- ANEB vs RSSS Comparison
ANEB vs RSSS Comparison
Compare ANEB & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- RSSS
- Stock Information
- Founded
- ANEB 2020
- RSSS 2006
- Country
- ANEB United States
- RSSS United States
- Employees
- ANEB N/A
- RSSS N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- RSSS Business Services
- Sector
- ANEB Health Care
- RSSS Consumer Discretionary
- Exchange
- ANEB Nasdaq
- RSSS Nasdaq
- Market Cap
- ANEB 111.8M
- RSSS 110.0M
- IPO Year
- ANEB 2021
- RSSS N/A
- Fundamental
- Price
- ANEB $2.76
- RSSS $3.32
- Analyst Decision
- ANEB Buy
- RSSS Strong Buy
- Analyst Count
- ANEB 2
- RSSS 1
- Target Price
- ANEB $8.00
- RSSS $5.00
- AVG Volume (30 Days)
- ANEB 25.7K
- RSSS 76.2K
- Earning Date
- ANEB 11-12-2025
- RSSS 11-13-2025
- Dividend Yield
- ANEB N/A
- RSSS N/A
- EPS Growth
- ANEB N/A
- RSSS N/A
- EPS
- ANEB N/A
- RSSS 0.04
- Revenue
- ANEB N/A
- RSSS $49,057,981.00
- Revenue This Year
- ANEB N/A
- RSSS $5.79
- Revenue Next Year
- ANEB N/A
- RSSS $8.46
- P/E Ratio
- ANEB N/A
- RSSS $82.25
- Revenue Growth
- ANEB N/A
- RSSS 9.94
- 52 Week Low
- ANEB $0.80
- RSSS $2.32
- 52 Week High
- ANEB $3.42
- RSSS $4.24
- Technical
- Relative Strength Index (RSI)
- ANEB 64.17
- RSSS 47.42
- Support Level
- ANEB $2.50
- RSSS $3.19
- Resistance Level
- ANEB $2.76
- RSSS $3.54
- Average True Range (ATR)
- ANEB 0.12
- RSSS 0.12
- MACD
- ANEB 0.03
- RSSS -0.03
- Stochastic Oscillator
- ANEB 85.00
- RSSS 39.50
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.